Garvan reaches 15,000 genomes

Garvan has now sequenced more than 15,000 whole genomes, a major milestone for the Kinghorn Centre for Clinical Genomics (KCCG) and Garvan’s wholly owned subsidiary, Genome.One.
27 July 2017

The Garvan Institute of Medical Research has now sequenced more than 15,000 whole genomes. The major milestone coincides with the first anniversary of the launch of Genome.One, a pioneering health information company providing genetic answers to health questions through clinical genome sequencing and analysis.

KCCG and Genome.One – who have been responsible for Garvan’s whole genome sequencing and analysis – have been at the forefront of clinical genomics, winning an award for precision analysis, building a reference bank of more than 3000 genomes, contributing to the development of new clinical tests, and helping to make life-changing diagnoses in almost 60% of clinical cases.

These achievements have been made possible by bringing together clinical and research expertise as part of a broader campus-wide initiative to enable precision healthcare. 

KCCG was established in 2012 by Garvan, with support from the Kinghorn Foundation, to advance the use of genomics in patient care. It was one of the first centres in the world to acquire an Illumina HiSeq X next-generation sequencing system. This made it possible to carry out large-scale genome sequencing more rapidly and cheaply, expanding opportunities for genomic research in NSW and partnering organisations across the globe.

Genome.One and KCCG continue to incorporate the latest technologies in their efforts to transform lives through genomics and to realise the clinical value of the genome. They are working towards a future of precision healthcare in Australia, as discussed in recent opinion pieces on investment in research and precision medicine by Garvan’s Executive Director, Professor John Mattick AO FAA.

Related People